Impact of COVID-19 on drug markets, use, harms and drug services in the community and prisons. Results from an EMCDDA trendspotter study April 2021

EMCDDA (2021)

In the third in its series of rapid ‘trendspotter’ studies, the EMCDDA explores the impact of COVID-19 on the drug situation and responses to it. Revisiting and reviewing findings from two studies in 2020 on the effects of the pandemic on drug use and services, the report identifies new trends and developments which may have implications for policy and practice. The report explores the situation in the EU Member States from June 2020 to February 2021, particularly changes in drug markets, patterns of use, harms and drug services, both in the community and in prisons.

Impact of COVID-19 on drug markets, use, harms and drug services in the community and prisons. Results from an EMCDDA trendspotter study April 2021

Impact of COVID-19 on drug markets, use, harms and drug services in the community and prisons. Results from an EMCDDA trendspotter study April 2021 (586)

PDF
English
In partnership with:
ISFF
FUAS
Correlation Network